Diagnostic News and Research

RSS

WHO report underlines need for quantum leap in TB care and control

Tuberculosis treatment has saved the lives of more than 22 million people, according to the WHO Global tuberculosis report 2013 published today. The report also reveals that the number of people ill with tuberculosis fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.

23 Oct 2013

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Beckman Coulter, Inc. announces the CE Mark approval of Access 25 (OH) Vitamin D Total assay for use on the Access 2 and UniCel DxI series of immunoassay systems. Offering enhanced performance, the new assay is an important addition to the company’s bone metabolism assay menu.

23 Oct 2013

Scientists from University of Salzburg, Sandoz Pharmaceuticals and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

The Christian Doppler Laboratory for Biosimilar Characterization is now open at the Paris-Lodron University of Salzburg, and scientists there have commenced developing new methods for characterizing proteins to be used in biopharmaceuticals.

23 Oct 2013

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

A new diagnostic platform to detect BRAF mutations in melanoma and other cancer types is faster and more accurate compared with the standard method currently used in clinics, and this could help accelerate diagnosis and treatment, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

IBM scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen.

23 Oct 2013

diaDexus amends agreement with Comerica Bank to expand existing loan facility

diaDexus, Inc., a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it has amended its agreement with Comerica Bank to expand its existing loan facility from $5 million to $10 million.

22 Oct 2013

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012.

22 Oct 2013

Professor wins Rhoda and Bernard Sarnat International Prize in Mental Health from Institute of Medicine

The Institute of Medicine today awarded the 2013 Rhoda and Bernard Sarnat International Prize in Mental Health to William T. Carpenter, professor of psychiatry and pharmacology at the University of Maryland School of Medicine, Baltimore.

22 Oct 2013

Interventions needed to boost hypertension diagnosis in young adults

Diagnosis of hypertension is often delayed in young adults, even if they make regular use of primary healthcare, report researchers.

21 Oct 2013

‘Limit diagnostic investigations’ in children with recurrent CAP

Research shows that pediatric recurrent community-acquired pneumonia in different lung areas is most commonly associated with mild conditions like rhinosinusitis and asthma, and not severe underlying disease.

21 Oct 2013

Personalis launches early access program to Personalis ACE Clinical Exome

Personalis, Inc., the leading provider of advanced medical exome and genome sequencing and interpretation services today announced the launch of an early access program to the Personalis ACE Clinical Exome, a single test that integrates enhanced exome sequencing with genome-wide structural variant detection to increase diagnostic yield.

21 Oct 2013

New collaborative project aims to discover genes underlying rare genetic diseases

...

21 Oct 2013

Hereditary high blood cholesterol overlooked and untreated worldwide

Hereditary high blood cholesterol leads to premature heart disease. It is overlooked and untreated virtually worldwide -- including in Europe. This is a major problem as the disease is dangerous for health. However, this disease is easy to diagnose and treat, according to the conclusion of a consensus report from the European Atherosclerosis Society.

21 Oct 2013

Genalyte Gets Grant From NCI To Develop Biomarker Panel For Cancer

...

18 Oct 2013

HBV-infected men more likely to develop liver cancer

A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.

18 Oct 2013

Psychotic symptoms alone denote medical health risk

People with symptoms of psychosis have an increased rate of medical comorbidities and unhealthy lifestyle habits even if they do not have a psychiatric diagnosis, shows a worldwide study.

17 Oct 2013

Blood-Based Protein Test May Distinguish Between Malignant And Benign Lung Nodules

...

17 Oct 2013

King's College researchers identify new biomarker that detects sepsis in blood

Researchers at King's College London have identified a biomarker - a biological 'fingerprint' - for sepsis in the blood, and showed it could be possible to diagnose the condition within two hours by screening for this biomarker at a patient's bedside.

17 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Researchers develop new tool to quantify myocardial damage in heart attack patients

Researchers from the Computer Vision Center (CVC) have developed a new tool to quantify the myocardial perfusion damage in people who had a heart attack or an angina. Having been validated in 200 patients, it can help improve and speed up diagnosis of the damage, offering a quantitative, repeatable and objective measure of the blood irrigation level of the heart tissue.

17 Oct 2013

Diagnostic News and Research

WHO report underlines need for quantum leap in TB care and control

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Scientists from University of Salzburg, Sandoz Pharmaceuticals and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

diaDexus amends agreement with Comerica Bank to expand existing loan facility

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

Professor wins Rhoda and Bernard Sarnat International Prize in Mental Health from Institute of Medicine

Interventions needed to boost hypertension diagnosis in young adults

‘Limit diagnostic investigations’ in children with recurrent CAP

Personalis launches early access program to Personalis ACE Clinical Exome

New collaborative project aims to discover genes underlying rare genetic diseases

Hereditary high blood cholesterol overlooked and untreated worldwide

Genalyte Gets Grant From NCI To Develop Biomarker Panel For Cancer

HBV-infected men more likely to develop liver cancer

Psychotic symptoms alone denote medical health risk

Blood-Based Protein Test May Distinguish Between Malignant And Benign Lung Nodules

King's College researchers identify new biomarker that detects sepsis in blood

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Researchers develop new tool to quantify myocardial damage in heart attack patients

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News